J9213 is a valid 2020 HCPCS code for Injection, interferon, alfa-2a, recombinant, 3 million units or just “Interferon alfa-2a inj” for short, used in Immunosuppressive drugs. J9213 has been in.
HCPCS Code : J9213. HCPCS Code Description: Injection, interferon, alfa-2a, recombinant, 3 million units, Pegasys (peginterferon alfa-2a) NOTICE This policy contains information which is clinical in nature. The policy is not medical advice. The information in this policy is used by Wellmark to make determinations whether medical treatment is covered under the terms of a Wellmark member’s health benefit plan.
26June2008 Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys ( peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.
Pegylated interferon alfa-2a, sold under the brand name Pegasys among others, is medication used to treat hepatitis C and hepatitis B. For hepatitis C it is typically used together with ribavirin and cure rates are between 24 and 92%. For hepatitis B it may be used alone. It is given by injection under the skin.. Side effects are common. They may include headache, feeling tired, depression …
Peginterferon alfa-2a – Wikipedia, Peginterferon alfa-2a – Wikipedia, Genentech : Pegasys® (peginterferon alfa-2a) – Information …
Peginterferon alfa-2a – Wikipedia, Peginterferon alfa-2a, is a covalent conjugate of recombinant alfa-2a interferon (approximate molecular weight [MW] 20,000 daltons) with a single branched bis-monomethoxy polyethylene glycol (PEG) chain (approximate MW 40,000 daltons). The PEG moiety is linked at a single site to the interferon alfa moiety via a stable amide bond to lysine.
